MX9305933A - Metodo para antagonizar al 1,4,5-trifosfato de inositol. - Google Patents
Metodo para antagonizar al 1,4,5-trifosfato de inositol.Info
- Publication number
- MX9305933A MX9305933A MX9305933A MX9305933A MX9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A
- Authority
- MX
- Mexico
- Prior art keywords
- inositol
- triphosphate
- antagonize
- oligometers
- formula
- Prior art date
Links
- MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 title abstract 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 230000001766 physiological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyurethanes Or Polyureas (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95239392A | 1992-09-28 | 1992-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9305933A true MX9305933A (es) | 1994-04-29 |
Family
ID=25492868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9305933A MX9305933A (es) | 1992-09-28 | 1993-09-27 | Metodo para antagonizar al 1,4,5-trifosfato de inositol. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0661982A1 (enExample) |
| JP (1) | JPH08502068A (enExample) |
| KR (1) | KR950703347A (enExample) |
| AU (1) | AU670962B2 (enExample) |
| CA (1) | CA2145681A1 (enExample) |
| HU (1) | HUT70192A (enExample) |
| IL (1) | IL107066A (enExample) |
| MX (1) | MX9305933A (enExample) |
| NO (1) | NO951163L (enExample) |
| NZ (1) | NZ256178A (enExample) |
| TW (1) | TW260663B (enExample) |
| WO (1) | WO1994007507A1 (enExample) |
| ZA (1) | ZA936978B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996000586A2 (en) * | 1994-06-30 | 1996-01-11 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Methods for treating cell proliferative disorders by modulating signal transduction |
| JPH11503110A (ja) | 1995-02-17 | 1999-03-23 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ−８受容体拮抗剤 |
| US5780483A (en) * | 1995-02-17 | 1998-07-14 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| US6083920A (en) * | 1995-12-21 | 2000-07-04 | Ayurcore, Inc. | Compositions for modulating intracellular inositol trisphosphate concentration |
| US6005008A (en) * | 1996-02-16 | 1999-12-21 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| US6262113B1 (en) | 1996-03-20 | 2001-07-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| US6211373B1 (en) | 1996-03-20 | 2001-04-03 | Smithkline Beecham Corporation | Phenyl urea antagonists of the IL-8 receptor |
| CZ425598A3 (cs) * | 1996-06-27 | 1999-08-11 | Smithkline Beecham Corporation | Antagonista IL-8 receptoru |
| US6271261B1 (en) | 1996-06-27 | 2001-08-07 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| AU2002214886A1 (en) * | 2000-11-09 | 2002-05-21 | Contrimmune Biotechnology Inc | Therapeutic uses for IP3 receptor-mediated calcium channel modulators |
| CN103930165B (zh) | 2011-09-02 | 2018-05-25 | 纽约市哥伦比亚大学理事会 | 用以治疗肥胖症的代谢紊乱的CaMKII、IP3R、钙调神经磷酸酶、P38和MK2/3抑制剂 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB781479A (en) * | 1953-08-27 | 1957-08-21 | Ciba Ltd | New polyureas and process for making them |
| US5276182A (en) * | 1990-07-09 | 1994-01-04 | The Dow Chemical Company | Process for preparing polyurea oligomers |
-
1993
- 1993-08-30 KR KR1019950701166A patent/KR950703347A/ko not_active Ceased
- 1993-08-30 NZ NZ256178A patent/NZ256178A/en unknown
- 1993-08-30 AU AU48417/93A patent/AU670962B2/en not_active Ceased
- 1993-08-30 WO PCT/US1993/008168 patent/WO1994007507A1/en not_active Ceased
- 1993-08-30 JP JP6509054A patent/JPH08502068A/ja active Pending
- 1993-08-30 HU HU9500891A patent/HUT70192A/hu unknown
- 1993-08-30 EP EP93921252A patent/EP0661982A1/en not_active Ceased
- 1993-08-30 CA CA002145681A patent/CA2145681A1/en not_active Abandoned
- 1993-09-21 ZA ZA936978A patent/ZA936978B/xx unknown
- 1993-09-22 IL IL107066A patent/IL107066A/en not_active IP Right Cessation
- 1993-09-22 TW TW082107787A patent/TW260663B/zh active
- 1993-09-27 MX MX9305933A patent/MX9305933A/es unknown
-
1995
- 1995-03-27 NO NO951163A patent/NO951163L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL107066A (en) | 1998-01-04 |
| HUT70192A (en) | 1995-09-28 |
| NO951163D0 (no) | 1995-03-27 |
| AU4841793A (en) | 1994-04-26 |
| AU670962B2 (en) | 1996-08-08 |
| JPH08502068A (ja) | 1996-03-05 |
| NZ256178A (en) | 1997-03-24 |
| CA2145681A1 (en) | 1994-04-14 |
| KR950703347A (ko) | 1995-09-20 |
| HU9500891D0 (en) | 1995-05-29 |
| TW260663B (enExample) | 1995-10-21 |
| EP0661982A1 (en) | 1995-07-12 |
| IL107066A0 (en) | 1993-12-28 |
| NO951163L (no) | 1995-03-27 |
| WO1994007507A1 (en) | 1994-04-14 |
| ZA936978B (en) | 1994-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE179892T1 (de) | Verwendung von lipid-gebundener glykoaminoglykanen zur behandlung der rheumatoider arthritis | |
| MX9305933A (es) | Metodo para antagonizar al 1,4,5-trifosfato de inositol. | |
| ATE206919T1 (de) | Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen | |
| CU23393A3 (es) | Compuestos inhibidores de la raf kinasa y composiciones farmacéuticas que los contienen | |
| BR0116001A (pt) | Métodos para tratar distúrbios neuropsiquiátricos com antagonistas receptores nmda | |
| ES2135083T3 (es) | Trifeniletilenos para la prevencion y el tratamiento de la osteoporosis. | |
| DE69022953D1 (de) | Zusammensetzungen zur Behandlung von Fettablagerungen. | |
| MX9303263A (es) | Antagonistas de la angiotensina ii, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen | |
| ES2116436T3 (es) | Carbamatos y agentes protectores de las plantas que les contienen. | |
| MX9204661A (es) | Compuestos intermedios derivados de eter y procedimiento para su preparacion. | |
| MX9202181A (es) | Compuestos arilicos y heteroarilicos bis mono y biciclicos que inhiben la tirosina quinasa de receptor de egf y/o pdgf. | |
| ES2070981T3 (es) | Concentrados de componente activo y nuevas combinaciones de componente activo de hojas de ginkgo biloba, sus metodos de preparacion y productos farmaceuticos que contienen los concentrados de componente activo o las combinaciones de componente activo. | |
| ES2189824T3 (es) | Antagonistas no peptidicos del receptor de taquiquininas. | |
| GB9514451D0 (en) | Sustained-release formulation | |
| MX9207494A (es) | 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. | |
| ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
| DE3867736D1 (de) | Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels. | |
| ES2058346T3 (es) | Compuestos piperidinilicos 1,4-disustituidos. | |
| GB2223169B (en) | Inositol trisphosphate for the treatment of bone disorders | |
| MX9401175A (es) | Inhibidores de la acetilcolinesterasa sililada. | |
| IT1247796B (it) | Derivati arilvinilamidici e procedimento per la loro preparazione | |
| MX9301298A (es) | Seudopeptidos, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| BR8902892A (pt) | Processo para a preparacao de hidrazinas substituidas e composicao inseticida | |
| SE9303853D0 (sv) | The use of an ester of inositoltrisphosphate for the preparing of medicaments | |
| AR059965A2 (es) | Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante |